Vanguard Personalized Indexing Management LLC Makes New Investment in Sotera Health (NASDAQ:SHC)

Vanguard Personalized Indexing Management LLC bought a new position in Sotera Health (NASDAQ:SHC) during the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 13,277 shares of the company’s stock, valued at approximately $158,000.

Several other hedge funds also recently bought and sold shares of the company. CWM LLC raised its holdings in Sotera Health by 86.1% in the second quarter. CWM LLC now owns 2,146 shares of the company’s stock worth $25,000 after purchasing an additional 993 shares during the period. Swiss National Bank raised its holdings in shares of Sotera Health by 0.5% during the first quarter. Swiss National Bank now owns 195,900 shares of the company’s stock worth $2,353,000 after acquiring an additional 1,000 shares during the period. TD Asset Management Inc raised its holdings in shares of Sotera Health by 1.5% during the second quarter. TD Asset Management Inc now owns 123,454 shares of the company’s stock worth $1,465,000 after acquiring an additional 1,800 shares during the period. Securian Asset Management Inc. raised its holdings in shares of Sotera Health by 23.0% during the first quarter. Securian Asset Management Inc. now owns 10,178 shares of the company’s stock worth $122,000 after acquiring an additional 1,900 shares during the period. Finally, State of Alaska Department of Revenue raised its holdings in shares of Sotera Health by 20.6% during the first quarter. State of Alaska Department of Revenue now owns 13,490 shares of the company’s stock worth $162,000 after acquiring an additional 2,300 shares during the period. 91.03% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at Sotera Health

In other news, Director Gtcr Investment Xi Llc sold 10,000,000 shares of Sotera Health stock in a transaction dated Friday, September 6th. The shares were sold at an average price of $15.03, for a total value of $150,300,000.00. Following the completion of the transaction, the director now owns 49,215,301 shares of the company’s stock, valued at approximately $739,705,974.03. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Company insiders own 55.12% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently commented on the stock. Royal Bank of Canada restated an “outperform” rating and set a $17.00 price objective on shares of Sotera Health in a report on Tuesday, August 6th. Barclays raised their price objective on shares of Sotera Health from $14.00 to $17.00 and gave the stock an “overweight” rating in a report on Tuesday, August 6th. Two analysts have rated the stock with a hold rating and four have given a buy rating to the stock. According to MarketBeat, Sotera Health currently has an average rating of “Moderate Buy” and a consensus target price of $15.70.

Sotera Health Stock Down 0.4 %

Shares of SHC stock opened at $16.70 on Tuesday. The company has a current ratio of 2.93, a quick ratio of 2.59 and a debt-to-equity ratio of 5.46. Sotera Health has a 1 year low of $10.71 and a 1 year high of $17.44. The firm’s fifty day moving average price is $15.32 and its two-hundred day moving average price is $12.95. The firm has a market capitalization of $4.73 billion, a P/E ratio of 87.89 and a beta of 2.07.

Sotera Health (NASDAQ:SHC) last issued its quarterly earnings results on Monday, August 5th. The company reported $0.19 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.15 by $0.04. Sotera Health had a net margin of 3.65% and a return on equity of 47.26%. The firm had revenue of $277.00 million for the quarter, compared to analyst estimates of $266.45 million. During the same period in the previous year, the business earned $0.19 EPS. The company’s revenue was up 8.6% compared to the same quarter last year. On average, equities analysts predict that Sotera Health will post 0.64 EPS for the current fiscal year.

Sotera Health Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.